Skip to content

KDK KDK Loss on issuance of equity instruments

Loss on issuance of equity instruments at other companies

Globalstar logo
GlobalstarGSAT
$0
John B. Sanfilippo & Son logo
John B. Sanfilippo & SonJBSS
$0
John B. Sanfilippo & Son logo
John B. Sanfilippo & SonJBSS
$0
Vestis logo
VestisVSTS
$0
ACI Worldwide logo
ACI WorldwideACIW
$0-100%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$246.5K

Other financials

Income statement

See full
Revenue$1.8M+24.4%
Operating income-$37.9M-104%
Net income$26.5M+121%
EPS (diluted)$0.10+105%

Balance sheet

See full
Cash & equivalents$66.4M+247%
Total debt$58.4M+1,068%
Total equity-$245.9M+34.7%
Total assets$130.8M-76.5%

Cash flow

See full
Operating cash flow-$29.5M-78.7%
CapEx$5.5M+138%
Free cash flow-$35.0M-86.0%

Valuation

See full
Market cap$1.05B-18.6%
Enterprise value$1.04B
P/S252.8×

Profitability

See full
Operating margin-2,695.8%
Net margin-10,366.9%
FCF margin-278%

Returns & leverage

See full
Return on equity-21.5%
Debt / equity-0.2×
Current ratio3.7×+3.4×

Where this comes from

Reported directly by KDK in its filing.

Tagged under the XBRL concept kdk:GainLossOnIssuanceOfEquityInstruments.

The official record: KDK’s 10-K, filed March 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about KDK's loss on issuance of equity instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KDK's loss on issuance of equity instruments?
KDK (KDK) reported loss on issuance of equity instruments of -$52.68M in Q4 2025.
What does loss on issuance of equity instruments mean?
This captures the accounting gain or loss recognized when equity instruments are issued, often in connection with debt settlements or complex financing arrangements. It represents the difference between the fair value of the equity issued and the carrying value of the obligations settled. This metric provides insight into the cost of capital and the impact of financing decisions on shareholder equity.